| Description |
MSI-1701 is an analogue of MSI-1436 which can control weight gain and blood glucose level extracted from patent US 7410959 B1.
|
| Related Catalog |
|
| In Vivo |
Analogues that differ from MSI-1436 at only a single stereocenter, such as MSI-1701 (the polyamine at C-3) or MSI-1777 (the methyl at C-20) exhibit significantly reduced activity, while MSI-1673 (the OH at C-7) is completely inactive[1].
|
| Animal Admin |
Experiments are performed using age-matched (4 to 5 weeks old) male mice provided food and water ad lib. Mice corresponding to a single experimental cohort are housed together in a single cage. Animals are used 1 week after arrival. Drug dosing is conducted with 10 mg/kg of each compound (including MSI-1701) via the i.p. route every 3 days for 4 doses, beginning on day 0[1].
|
| References |
[1]. Michael Zasloff, et al. Therapeutic uses for aminosterol compounds. US 7410959 B1.
|
